THE RESEARCH

1. Adams, J. D. (2021). Probable Causes of Alzheimer’s Disease. Sci, 3(1), 16.

2. Arendt, J. F. H., Horváth-Puhó, E., Sørensen, H. T., Nexø, E., Pedersen, L., Ording, A. G., & Henderson, V. W. (2021). Plasma Vitamin B12 Levels, High-Dose Vitamin B12 Treatment, and Risk of Dementia. Journal of Alzheimer's Disease, (Preprint), 1-12.

3. Asl, Z. R., Sepehri, G., & Salami, M. (2019). Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease. Behavioural brain research, 376, 112183.

4. Avgerinos, K. I., Spyrou, N., Bougioukas, K. I., & Kapogiannis, D. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials. Experimental gerontology, 108, 166-173.

5. Babina, K., Salikhova, D., Polyakova, M., Svitich, O., Samoylikov, R., Ahmad El-Abed, S., ... & Novozhilova, N. (2022). The Effect of Oral Probiotics (Streptococcus Salivarius k12) on the Salivary Level of Secretory Immunoglobulin A, Salivation Rate, and Oral Biofilm: A Pilot Randomized Clinical Trial. Nutrients, 14(5), 1124.

6. Bai, D., Fan, J., Li, M., Dong, C., Gao, Y., Fu, M., ... & Liu, H. (2021). Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial. Journal of Alzheimer's Disease, (Preprint), 1-13.

7. Baker, L. B. (2019). Physiology of sweat gland function: The roles of sweating and sweat composition in human health. Temperature, 6(3), 211-259.

8. Bartochowski, Z., Conway, J., Wallach, Y., Chakkamparambil, B., Alakkassery, S., & Grossberg, G. T. (2020). Dietary interventions to prevent or delay alzheimer’s disease: what the evidence shows. Current Nutrition Reports, 1-16.

9. Butler, M., Nelson, V. A., Davila, H., Ratner, E., Fink, H. A., Hemmy, L. S., ... & Kane, R. L. (2018). Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Annals of internal medicine, 168(1), 52-62.

10. Cardinali, D. P. (2019). Melatonin: clinical perspectives in neurodegeneration. Frontiers in endocrinology, 10, 480.

11. Cardoso, B. R., Roberts, B. R., Malpas, C. B., Vivash, L., Genc, S., Saling, M. M., ... & Bush, A. I. (2019). Supranutritional sodium selenate supplementation delivers selenium to the central nervous system: results from a randomized controlled pilot trial in Alzheimer’s disease. Neurotherapeutics, 16(1), 192-202.

12. Chan, D., Suk, H. J., Jackson, B., Milman, N. P., Stark, D., Klerman, E. B., ... & Tsai, L. H. (2021). 40Hz sensory stimulation induces gamma entrainment and affects brain structure, sleep and cognition in patients with Alzheimer’s dementia. medRxiv, 2021-03.

13. Chang, C. H., Lin, C. H., & Lane, H. Y. (2020). d-glutamate and Gut Microbiota in Alzheimer’s Disease. International journal of molecular sciences, 21(8), 2676.

14. Chen, J. Y., Zhu, Q., Zhang, S., OuYang, D., & Lu, J. H. (2019). Resveratrol in experimental Alzheimer’s disease models: A systematic review of preclinical studies. Pharmacological research, 150, 104476.

15. de Wilde, M. C., Vellas, B., Girault, E., Yavuz, A. C., & Sijben, J. W. (2017). Lower brain and blood nutrient status in Alzheimer's disease: results from meta-analyses. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 3(3), 416-431.

16. Den, H., Dong, X., Chen, M., & Zou, Z. (2020). Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment—A meta-analysis of randomized controlled trials. Aging (Albany NY), 12(4), 4010.

17. Dhaynaut, M., Cappon, D., Paciorek, R., Macone, J., Connor, A., Guehl, N., ... & Santarnecchi, E. (2020). Effects of modulating gamma oscillations via 40Hz transcranial alternating current stimulation (tACS) on Tau PET imaging in mild to moderate Alzheimer’s Disease.

18. Eiser, A. (2019, April). Sauna Bathing and Healthy Sweating: II. In Mayo Clinic Proceedings (Vol. 94, No. 4, p. 727). Elsevier.

19. Etter, G., van der Veldt, S., Manseau, F., Zarrinkoub, I., Trillaud-Doppia, E., & Williams, S. (2019). Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model. Nature communications, 10(1), 1-11.

20. Ferrer, M. D., López-López, A., Nicolescu, T., Perez-Vilaplana, S., Boix-Amorós, A., Dzidic, M., ... & Mira, A. (2020). Topic application of the probiotic Streptococcus dentisani improves clinical and microbiological parameters associated with oral health. Frontiers in cellular and infection microbiology, 10, 465.

21. Fink, H. A., Jutkowitz, E., McCarten, J. R., Hemmy, L. S., Butler, M., Davila, H., ... & Kane, R. L. (2018). Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Annals of internal medicine, 168(1), 39-51.

22. Frydman-Marom, A., Levin, A., Farfara, D., Benromano, T., Scherzer-Attali, R., Peled, S., ... & Ovadia, M. (2011). Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PloS one, 6(1), e16564.

23. Gasperi, V., Sibilano, M., Savini, I., & Catani, M. V. (2019). Niacin in the central nervous system: an update of biological aspects and clinical applications. International journal of molecular sciences, 20(4), 974.

24. Genuis, S. K., Birkholz, D., & Genuis, S. J. (2017). Human excretion of polybrominated diphenyl ether flame retardants: blood, urine, and sweat study. BioMed research international, 2017.

25. Gheisary, Z., Mahmood, R., Harri shivanantham, A., Liu, J., Lieffers, J. R., Papagerakis, P., & Papagerakis, S. (2022). The Clinical, Microbiological, and Immunological Effects of Probiotic Supplementation on Prevention and Treatment of Periodontal Diseases: A Systematic Review and Meta-Analysis. Nutrients, 14(5), 1036.

26. Gu, J., Li, Z., Chen, H., Xu, X., Li, Y., & Gui, Y. (2021). Neuroprotective effect of trans-resveratrol in mild to moderate Alzheimer disease: a randomized, double-blind trial. Neurology and Therapy, 10(2), 905-917.

27. Gu, L., & Guo, Z. (2013). Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils. Journal of neurochemistry, 126(3), 305-311.

28. Hale, J. D. F., Jain, R., Wescombe, P. A., Burton, J. P., Simon, R. R., & Tagg, J. R. (2022). Safety assessment of Streptococcus salivarius M18 a probiotic for oral health. Beneficial Microbes, 13(1), 47-60.

29. Hoffmann, J., Busse, S., von Hoff, F., Borucki, K., Frodl, T., & Busse, M. (2021). Association Between Homocysteine and Vitamin Levels in Demented Patients. Journal of Alzheimer's Disease, (Preprint), 1-12.

30. Iniesta, M., Herrera, D., Montero, E., Zurbriggen, M., Matos, A. R., Marín, M. J., ... & Sanz, M. (2012). Probiotic effects of orally administered Lactobacillus reuteri‐containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. Journal of clinical periodontology, 39(8), 736-744.

31. Ismail, R., Hansen, A. K., Parbo, P., Brændgaard, H., Gottrup, H., Brooks, D. J., & Borghammer, P. (2018). The effect of 40-Hz light therapy on amyloid load in patients with prodromal and clinical Alzheimer’s disease. International Journal of Alzheimer’s Disease, 2018.

32. Jatoi, S., Hafeez, A., Riaz, S. U., Ali, A., Ghauri, M. I., & Zehra, M. (2020). Low Vitamin B12 levels: An underestimated cause of minimal cognitive impairment and dementia. Cureus, 12(2).

33. Katakam, N., & Durgaraju, S. (2020). Prevalence of vitamin B12 deficiency in elderly population with dementia. International Journal of Health and Clinical Research, 3(12), 110-114.

34. Khambholja, D. B., Kumar, P., Joshi, R. G., & Patel, H. V. (2022). Role of probiotics in the prevention and treatment of oral diseases. In Probiotics in the Prevention and Management of Human Diseases (pp. 251-264). Academic Press.

35. Kim, J. W., Hahn, K. R., Yoo, D. Y., Jung, H. Y., Hwang, I. K., Seong, J. K., & Yoon, Y. S. (2019). Methionine-choline deprivation impairs adult hippocampal neurogenesis in C57BL/6 mice. Journal of medicinal food, 22(4), 344-354.

36. Krüger, J. F., Hillesheim, E., Pereira, A. C., Camargo, C. Q., & Rabito, E. I. (2021). Probiotics for dementia: a systematic review and meta-analysis of randomized controlled trials. Nutrition reviews, 79(2), 160-170.

37. Kryscio, R. J., Abner, E. L., Caban-Holt, A., Lovell, M., Goodman, P., Darke, A. K., ... & Schmitt, F. A. (2017). Association of antioxidant supplement use and dementia in the prevention of Alzheimer’s disease by vitamin E and selenium trial (PREADViSE). JAMA neurology, 74(5), 567-573.

38. Labban, S., Alghamdi, B. S., Alshehri, F. S., & Kurdi, M. (2021). Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease. Behavioural Brain Research, 402, 113100.

39. Lane, H. Y., Tu, C. H., Lin, W. C., & Lin, C. H. (2021). Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial. International Journal of Neuropsychopharmacology, 24(5), 392-399.

40. Lee, J., Ryu, S., Kim, H. J., Jung, J., Lee, B., & Kim, T. (2018). 40 Hz acoustic stimulation decreases amyloid beta and modulates brain rhythms in a mouse model of Alzheimer’s disease. bioRxiv, 390302.

41. Li, C., Wang, N., Zheng, G., & Yang, L. (2021). Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota. ACS Applied Materials & Interfaces, 13(39), 46406-46420.

42. Li, M., Li, W., Gao, Y., Chen, Y., Bai, D., Weng, J., ... & Huang, G. (2021). Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial. European Journal of Nutrition, 60(4), 1795-1808.

43. Li, Y., Zhang, J., Wan, J., Liu, A., & Sun, J. (2020). Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease. Biomedicine & Pharmacotherapy, 132, 110887.

44. Lin, C. H., Chen, P. K., Chang, Y. C., Chuo, L. J., Chen, Y. S., Tsai, G. E., & Lane, H. Y. (2014). Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial. Biological psychiatry, 75(9), 678-685.

45. Lin, C. W., Chen, Y. T., Ho, H. H., Hsieh, P. S., Kuo, Y. W., Lin, J. H., ... & Yang, S. F. (2021). Lozenges with probiotic strains enhance oral immune response and health. Oral Diseases.

46. López-Gambero, A. J., Sanjuan, C., Serrano-Castro, P. J., Suárez, J., & Rodríguez de Fonseca, F. (2020). The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases. Biomedicines, 8(9), 295.

47. Lukiw, W. J. (2020). Treating Alzheimer’s Disease (AD) with Light and Sound. Journal of Alzheimer's disease & Parkinsonism, 10(2).

48. Ma, F., Li, Q., Zhou, X., Zhao, J., Song, A., Li, W., ... & Huang, G. (2019). Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial. European journal of nutrition, 58(1), 345-356.

49. Ma, F., Zhou, X., Li, Q., Zhao, J., Song, A., An, P., ... & Huang, G. (2019). Effects of folic acid and vitamin B12, alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: A single-blind experimental design. Current Alzheimer Research, 16(7), 622-632.

50. Madhavadas, S., & Subramanian, S. (2017). Cognition enhancing effect of the aqueous extract of Cinnamomum zeylanicum on non-transgenic Alzheimer's disease rat model: Biochemical, histological, and behavioural studies. Nutritional neuroscience, 20(9), 526-537.

51. Martorell, A. J., Paulson, A. L., Suk, H. J., Abdurrob, F., Drummond, G. T., Guan, W., ... & Tsai, L. H. (2019). Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell, 177(2), 256-271.

52. McLaurin, J., Golomb, R., Jurewicz, A., Antel, J. P., & Fraser, P. E. (2000). Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity. Journal of Biological Chemistry, 275(24), 18495-18502.

53. Mielech, A., Puścion-Jakubik, A., Markiewicz-Żukowska, R., & Socha, K. (2020). Vitamins in alzheimer’s disease—Review of the latest reports. Nutrients, 12(11), 3458.

54. Mihardja, M., Roy, J., Wong, K. Y., Aquili, L., Heng, B. C., Chan, Y. S., ... & Lim, L. W. (2020). Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease. Annals of the New York Academy of Sciences, 1478(1), 43-62.

55. Miki, A., Kinno, R., Ochiai, H., Kubota, S., Mori, Y., Futamura, A., ... & Ono, K. (2021). Sex Differences in the Relationship of Serum Vitamin B1 and B12 to Dementia Among Memory Clinic Outpatients in Japan. Frontiers in Aging Neuroscience, 13, 169.

56. Modi, K. K., Roy, A., Brahmachari, S., Rangasamy, S. B., & Pahan, K. (2015). Cinnamon and its metabolite sodium benzoate attenuate the activation of p21rac and protect memory and learning in an animal model of Alzheimer’s disease. PloS one, 10(6), e0130398.

57. Momtaz, S., Hassani, S., Khan, F., Ziaee, M., & Abdollahi, M. (2018). Cinnamon, a promising prospect towards Alzheimer’s disease. Pharmacological research, 130, 241-258.

58. Moreira, S. C., Jansen, A. K., & Silva, F. M. (2020). Dietary interventions and cognition of Alzheimer’s disease patients: A systematic review of randomized controlled trial. Dementia & Neuropsychologia, 14, 258-282.

59. Moreira, S. C., Jansen, A. K., & Silva, F. M. (2020). Dietary interventions and cognition of Alzheimer’s disease patients: A systematic review of randomized controlled trial. Dementia & Neuropsychologia, 14, 258-282.

60. Moutinho, M., Tsai, A. P., Puntambekar, S. S., Patel, J., Lin, P. B., Jadhav, V., ... & Landreth, G. E. (2020). Therapeutic potential of niacin in Alzheimer's disease: Nonhuman/Target identification and validation studies: Other. Alzheimer's & Dementia, 16, e040679.

61. Mustafa, I., Awad, A., Fgaier, H., Mansur, A., & Elkamel, A. (2021). Compartmental modeling and analysis of the effect of β-amyloid on acetylcholine neurocycle via choline leakage hypothesis. Computers & Chemical Engineering, 145, 107165.

62. Nous, A., Engelborghs, S., & Smolders, I. (2021). Melatonin levels in the Alzheimer’s disease continuum: a systematic review. Alzheimer's Research & Therapy, 13(1), 1-12.

63. Park, S. S., Park, H. S., Kim, C. J., Kang, H. S., Kim, D. H., Baek, S. S., & Kim, T. W. (2020). Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease. Alzheimer's Research & Therapy, 12, 1-15.

64. Peterson, D. W., George, R. C., Scaramozzino, F., LaPointe, N. E., Anderson, R. A., Graves, D. J., & Lew, J. (2009). Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. Journal of Alzheimer's Disease, 17(3), 585-597.

65. Przybelski, A. G., Vogt, N. M., Bendlin, B. B., & Przybelski, R. J. (2020). Vitamin deficiencies in geriatric memory patients: Other innovative programs and practices. Alzheimer's & Dementia, 16, e038765.

66. Rashedinia, M., Saberzadeh, J., Khodaei, F., Mashayekhi Sardoei, N., Alimohammadi, M., & Arabsolghar, R. (2020). Effect of sodium benzoate on apoptosis and mitochondrial membrane potential after aluminum toxicity in PC-12 cell line. Iranian Journal of Toxicology, 14(4), 237-244.

67. Regidor, P. A., & Schindler, A. E. (2016). Myoinositol as a safe and alternative approach in the treatment of infertile PCOS women: a German observational study. International journal of endocrinology, 2016.

68. Roschel, H., Gualano, B., M Ostojic, S., & S Rawson, E. (2021). Creatine Supplementation and Brain Health. Nutrients, 13(2), 586.

69. Russo, M., Forte, G., Montanino Oliva, M., Laganà, A. S., & Unfer, V. (2021). Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to Birth. International Journal of Molecular Sciences, 22(16), 8433.

70. Sashindran, V. K., Aggarwal, V., & Khera, A. (2021). Prevalence of Vitamin B12 deficiency in elderly population (> 60 years) presenting with dementia to outpatient department. Medical Journal Armed Forces India.

71. Schlagenhauf, U., Jakob, L., Eigenthaler, M., Segerer, S., Jockel‐Schneider, Y., & Rehn, M. (2016). Regular consumption of Lactobacillus reuteri‐containing lozenges reduces pregnancy gingivitis: an RCT. Journal of clinical periodontology, 43(11), 948-954.

72. Scholefield, M., Church, S. J., Xu, J., Patassini, S., Hooper, N. M., Unwin, R. D., & Cooper, G. J. (2021). Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia. Metabolites, 11(9), 569.

73. Shukla, M., Govitrapong, P., Boontem, P., Reiter, R. J., & Satayavivad, J. (2017). Mechanisms of melatonin in alleviating Alzheimer's disease. Current neuropharmacology, 15(7), 1010-1031.

74. Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., ... & Lindquist, S. (2021). APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Science translational medicine, 13(583).

75. Singer, A. C., Martorell, A. J., Douglas, J. M., Abdurrob, F., Attokaren, M. K., Tipton, J., ... & Tsai, L. H. (2018). Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load. Nature protocols, 13(8), 1850-1868.

76. Siquier-Coll, J., Bartolomé, I., Pérez-Quintero, M., Muñoz, D., Robles, M. C., & Maynar-Mariño, M. (2020). Effect of exposure to high temperatures in the excretion of cadmium and lead. Journal of thermal biology, 89, 102545.

77. Smolarek, A. C., McAnulty, S. R., Ferreira, L. H., Cordeiro, G. R., Alessi, A., Rebesco, D. B., ... & Souza-Junior, T. P. (2020). Effect of 16 Weeks of Strength Training and Creatine Supplementation on Strength and Cognition in Older Adults: A Pilot Study. Journal of Exercise Physiology Online, 23(4).

78. Snow, W. M., Cadonic, C., Cortes-Perez, C., Adlimoghaddam, A., Roy Chowdhury, S. K., Thomson, E., ... & Albensi, B. C. (2020). Sex-specific effects of chronic creatine supplementation on hippocampal-mediated spatial cognition in the 3xTg mouse model of Alzheimer’s disease. Nutrients, 12(11), 3589.

79. Soininen, H., Solomon, A., Visser, P. J., Hendrix, S. B., Blennow, K., Kivipelto, M., ... & LipiDiDiet Clinical Study Group. (2021). 36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease. Alzheimer's & Dementia, 17(1), 29.

80. Spera, V., Sitnikova, T., Ward, M. J., Farzam, P., Hughes, J., Gazecki, S., ... & Cassano, P. (2021). Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer’s Disease. Journal of Alzheimer's Disease, (Preprint), 1-18.

81. Synoradzki, K., & Grieb, P. (2019). Citicoline: A superior form of choline?. Nutrients, 11(7), 1569.

82. Tamtaji, O. R., Heidari-Soureshjani, R., Mirhosseini, N., Kouchaki, E., Bahmani, F., Aghadavod, E., ... & Asemi, Z. (2019). Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: a randomized, double-blind, controlled trial. Clinical Nutrition, 38(6), 2569-2575.

83. Theodoro, L. H., Claudio, M. M., Nuernberg, M. A. A., Miessi, D. M. J., Batista, J. A., Duque, C., & Garcia, V. G. (2019). Effects of Lactobacillus reuteri as an adjunct to the treatment of periodontitis in smokers: randomised clinical trial. Beneficial microbes, 10(4), 375-384.

84. Turner, R. S., Thomas, R. G., Craft, S., Van Dyck, C. H., Mintzer, J., Reynolds, B. A., ... & Aisen, P. S. (2015). A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology, 85(16), 1383-1391.

85. Velazquez, R., Ferreira, E., Winslow, W., Dave, N., Piras, I. S., Naymik, M., ... & Oddo, S. (2020). Maternal choline supplementation ameliorates Alzheimer’s disease pathology by reducing brain homocysteine levels across multiple generations. Molecular psychiatry, 25(10), 2620-2629.

86. Velazquez, R., Winslow, W., & Mifflin, M. A. (2020). Choline as a prevention for Alzheimer’s disease. Aging (Albany NY), 12(3), 2026.

87. Vivekananda, M. R., Vandana, K. L., & Bhat, K. G. (2010). Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. Journal of oral microbiology, 2(1), 5344.

88. Wang, Y. Y., Zheng, W., Ng, C. H., Ungvari, G. S., Wei, W., & Xiang, Y. T. (2017). Meta‐analysis of randomized, double‐blind, placebo‐controlled trials of melatonin in Alzheimer's disease. International Journal of Geriatric Psychiatry, 32(1), 50-57.

89. Xu, J., Patassini, S., Begley, P., Church, S., Waldvogel, H. J., Faull, R. L., ... & Cooper, G. J. (2020). Cerebral deficiency of vitamin B5 (D-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer’s disease. Biochemical and biophysical research communications, 527(3), 676-681.

90. Yao, Y., Ying, Y., Deng, Q., Zhang, W., Zhu, H., Lin, Z., ... & Zhao, Y. (2020). Non-invasive 40-Hz light flicker ameliorates Alzheimer’s-associated rhythm disorder via regulating central circadian clock in mice. Frontiers in physiology, 11, 294.

91. Zhang, C., Luo, J., Yuan, C., & Ding, D. (2020). Vitamin B12, B6, or folate and cognitive function in community-dwelling older adults: A systematic review and meta-analysis. Journal of Alzheimer's Disease, (Preprint), 1-14.

92. Zhang, Y., Ding, Y., & Guo, Q. (2022). Probiotic Species in the Management of Periodontal Diseases: An Overview. Frontiers in Cellular and Infection Microbiology, 308.

93. Zhu, G., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021). Probiotics for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Foods, 10(7), 1672.

94. Yagami, T., Ueda, K., Asakura, K., Sakaeda, T., Nakazato, H., Kuroda, T., ... & Tsuzuki, H. (2002). Gas6 rescues cortical neurons from amyloid β protein-induced apoptosis. Neuropharmacology, 43(8), 1289-1296.

95. Rivers-Auty, J., Tapia, V. S., White, C. S., Daniels, M. J., Drinkall, S., Kennedy, P. T., ... & Lawrence, C. B. (2021). Zinc status alters Alzheimer's disease progression through NLRP3-dependent inflammation. Journal of Neuroscience, 41(13), 3025-3038.

96. Shah, R. C., Buchman, A. S., Wilson, R. S., Leurgans, S. E., & Bennett, D. A. (2011). Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology, 77(3), 219-226.

97. Rao, R. V., Kumar, S., Gregory, J., Coward, C., Okada, S., Lipa, W., ... & Bredesen, D. E. (2021). ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. Biomedicines, 9(10), 1348.

98. Baker et al., 2021. Impact of cocoa flavanols and multivitamins on cognitive function: findings of the cocoa supplement and multivitamin outcomes study of cognition (cosmos-mind). Symposia — Oral Communications — Late Breaking News. J Prev Alzheimers Dis 8 (Suppl 1), S1–S72 (2021). https://doi.org/10.14283/jpad.2021.57

99. Li, M., Li, W., Gao, Y., Chen, Y., Bai, D., Weng, J., ... & Huang, G. (2021). Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial. European Journal of Nutrition, 60(4), 1795-1808.

100. Abdelhamid, M., Zhou, C., Ohno, K., Kuhara, T., Taslima, F., Abdullah, M., ... & Michikawa, M. (2021). Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-β production and microglia activation in APP knock-in mouse. Journal of Alzheimer's Disease, (Preprint), 1-17.

101. Ruiz-Gonzalez, C., Roman, P., Rueda-Ruzafa, L., Rodriguez-Arrastia, M., & Cardona, D. (2021). Effects of probiotics supplementation on dementia and cognitive impairment: A systematic review and meta-analysis of preclinical and clinical studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 108, 110189.

102. Ahmadi, S., Wang, S., Nagpal, R., Wang, B., Jain, S., Razazan, A., ... & Yadav, H. (2020). A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis. JCI insight, 5(9).

103. Gou, H., Chen, X., Li, L., Wang, X., & Xu, Y. (2020). Additional clinical benefits of probiotics as an adjunctive therapy to nonsurgical periodontal treatment of periodontitis: a systematic review and meta-analysis.

104. Sureda, A., Daglia, M., Castilla, S. A., Sanadgol, N., Nabavi, S. F., Khan, H., ... & Nabavi, S. M. (2020). Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome?. Pharmacological research, 151, 104582.

105. Dioguardi, M., Crincoli, V., Laino, L., Alovisi, M., Sovereto, D., Mastrangelo, F., ... & Lo Muzio, L. (2020). The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer’s disease: a systematic review. Journal of clinical medicine, 9(2), 495.

106. Sumsuzzman, D. M., Choi, J., Jin, Y., & Hong, Y. (2021). Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials. Neuroscience & Biobehavioral Reviews, 127, 459-473.

107. Lo, K., Liu, Q., Madsen, T., Rapp, S., Chen, J. C., Neuhouser, M., ... & Liu, S. (2019). Relations of magnesium intake to cognitive impairment and dementia among participants in the Women’s Health Initiative Memory Study: a prospective cohort study. BMJ open, 9(11), e030052.

108. Toffa, D. H., Magnerou, M. A., Kassab, A., Djibo, F. H., & Sow, A. D. (2019). Can magnesium reduce central neurodegeneration in Alzheimer's disease? Basic evidences and research needs. Neurochemistry International, 126, 195-202.

109. Cho, J. H., Bhutani, S., Kim, C. H., & Irwin, M. R. (2021). Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials. Brain, behavior, and immunity, 93, 245-253.

110. Camp, O. G., Bai, D., Gonullu, D. C., Nayak, N., & Abu-Soud, H. M. (2021). Melatonin interferes with COVID-19 at several distinct ROS-related steps. Journal of Inorganic Biochemistry, 223, 111546.

111. Chan, V., & Lo, K. (2022). Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgraduate Medical Journal, 98(1158), 285-293.

112. Schaefer, S. M., Kaiser, A., Behrendt, I., Eichner, G., & Fasshauer, M. (2022). Association of Alcohol Types, Coffee, and Tea Intake with Risk of Dementia: Prospective Cohort Study of UK Biobank Participants. Brain Sciences, 12(3), 360.

113. Benussi, A., Cantoni, V., Cotelli, M. S., Cotelli, M., Brattini, C., Datta, A., ... & Borroni, B. (2021). Exposure to gamma tACS in Alzheimer’s disease: A randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimulation, 14(3), 531-540.

114. Wood, J. N., & Will, C. (2022). Can a Digital Therapy Using Sound and Light Reset the Balance of Alzheimer’s Disease?. Science Insights, 40(2), 427-430.

115. Agger, M. P., Carstensen, M. S., Henney, M. A., Hansen, L. S., Baandrup, A. O., Nguyen, M., ... & Kjær, T. W. (2022). Novel invisible spectral flicker induces 40 Hz neural entrainment with similar spatial distribution as 40 Hz stroboscopic light. Journal of Alzheimer's Disease, 88(1), 335.

116. Grent, T., Gajwani, R., Gross, J., Gumley, A. I., Krishnadas, R., Lawrie, S. M., ... & Uhlhaas, P. J. (2021). 40-Hz auditory steady-state responses characterize circuit dysfunctions and predict clinical outcomes in clinical high-risk for psychosis participants: a magnetoencephalography study. Biological Psychiatry, 90(6), 419-429.

117. Dhaynaut, M., Sprugnoli, G., Cappon, D., Macone, J., Sanchez, J. S., Normandin, M., ... & Santarnecchi, E. (2022). Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer’s Disease: A Case Series. Journal of Alzheimer's Disease, (Preprint), 1-10.

118. Grover, S., Wen, W., Viswanathan, V., Gill, C. T., & Reinhart, R. M. (2022). Long-lasting, dissociable improvements in working memory and long-term memory in older adults with repetitive neuromodulation. Nature Neuroscience, 1-10.

119. Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Barnes, L. L., Bennett, D. A., & Aggarwal, N. T. (2015). MIND diet slows cognitive decline with aging. Alzheimer's & dementia, 11(9), 1015-1022.

120. Ma, F., Li, Q., Zhou, X., Zhao, J., Song, A., Li, W., ... & Huang, G. (2019). Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial. European journal of nutrition, 58(1), 345-356.

121. Grodstein, F., O’Brien, J., Kang, J. H., Dushkes, R., Cook, N. R., Okereke, O., ... & Sesso, H. D. (2013). Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of internal medicine, 159(12), 806-814.

122. Popescu, A., & German, M. (2021). Vitamin K2 Holds Promise for Alzheimer’s Prevention and Treatment. Nutrients, 13(7), 2206.

123. Grover, S., Wen, W., Viswanathan, V., Gill, C. T., & Reinhart, R. M. (2022). Long-lasting, dissociable improvements in working memory and long-term memory in older adults with repetitive neuromodulation. Nature Neuroscience, 1-10.

124. Venturino, A., Schulz, R., De Jesús-Cortés, H., Maes, M. E., Nagy, B., Reilly-Andújar, F., ... & Siegert, S. (2021). Microglia enable mature perineuronal nets disassembly upon anesthetic ketamine exposure or 60-Hz light entrainment in the healthy brain. Cell reports, 36(1), 109313.

125. Zhou, D., Li, A., Li, X., Zhuang, W., Liang, Y., Zheng, C. Y., ... & Yuan, T. F. (2022). Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer’s disease: a randomised, double-blind, sham-controlled clinical trial. Journal of Neurology, Neurosurgery & Psychiatry, 93(5), 568-570.

126. Shen, Q., Wu, X., Zhang, Z., Zhang, D., Yang, S., & Xing, D. (2022). Gamma frequency light flicker regulates amyloid precursor protein trafficking for reducing β‐amyloid load in Alzheimer's disease model. Aging Cell, 21(3), e13573.

127. Han, C., Zhao, X., Li, M., Haihambo, N., Teng, J., Li, S., ... & Gao, M. (2022). Enhancement of the neural response during 40 Hz auditory entrainment in closed-eye state in human prefrontal region. Cognitive Neurodynamics, 1-12.

128. Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., ... & Salami, M. (2016). Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Frontiers in aging neuroscience, 8, 256.

129. Kim, S. H., Yang, J. W., Kim, K. H., Kim, J. U., & Yook, T. H. (2019). A Review on Studies of Marijuana for Alzheimer’s Disease–Focusing on CBD, THC. Journal of pharmacopuncture, 22(4), 225.

130. Hao, F., & Feng, Y. (2021). Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq. Life Sciences, 264, 118624.

131. Farr, S. A., Goodland, M. N., Niehoff, M. L., Banerjee, S., & Young, B. J. (2021). Cannabidiol (CBD) improves cognition and decreases anxiety in the SAMP8 mouse model of Alzheimer’s. Alzheimer's & Dementia, 17, e054428.

132. Drożak, P., Skrobas, U., & Drożak, M. (2022). Cannabidiol in the treatment and prevention of Alzheimer’s disease–a comprehensive overview of in vitro and in vivo studies. Journal of Education, Health and Sport, 12(9), 834-845.

133. Kreilaus, F., Przybyla, M., Ittner, L., & Karl, T. (2022). Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice. Behavioural Brain Research, 425, 113812.

134. Prasad, K. N. (2022). A Micronutrient Mixture with Collagen Peptides, Probiotics, Cannabidiol, and diet may Reduce Aging, and Development and Progression of Age-Related Alzheimer’s Disease, and Improve its Treatment. Mechanisms of Ageing and Development, 111757.

135. Pautex, S., Bianchi, F., Daali, Y., Augsburger, M., De Saussure, C., Wampfler, J., ... & Broers, B. (2022). Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. Frontiers in Aging Neuroscience, 14.

136. Aziz, A. I., Nguyen, L. C., Oumeslakht, L., Bensussan, A., & Ben Mkaddem, S. (2022). Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations. Cannabis and Cannabinoid Research.

137. Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., ... & Bredesen, D. E. (2022). Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project. Journal of Alzheimer’s Disease, 88(4), 1411-1421. 

138. https://www.bcbs.com/the-health-of-america/reports/early-onset-dementia-alzheimers-disease-affecting-younger-american-adults(Anthem research. The average age of onset is 49.)

139. Tass, P. A. (2022). Vibrotactile coordinated reset stimulation for the treatment of Parkinson's disease. Neural Regeneration Research, 17(7), 1495.

140. Pfeifer, K. J., Kromer, J. A., Cook, A. J., Hornbeck, T., Lim, E. A., Mortimer, B. J., ... & Tass, P. A. (2021). Coordinated reset vibrotactile stimulation induces sustained cumulative benefits in Parkinson’s disease. Frontiers in physiology, 12, 624317.

141. Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., ... & Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446.

142. Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R. (2019). A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. Journal of Alzheimer's Disease, 70(s1), S165-S186.

143. Zhang, Y., Chen, S. D., Deng, Y. T., You, J., He, X. Y., Wu, X. R., ... & Yu, J. T. (2023). Identifying modifiable factors and their joint effect on dementia risk in the UK Biobank. Nature Human Behaviour, 1-11.

144. Bransby, L., Rosenich, E., Buckley, R. F., Yassi, N., Pase, M. P., Maruff, P., & Lim, Y. Y. (2023). Multidomain modifiable dementia risk factors are associated with poorer cognition in midlife. Neuropsychology.

145. Gong, J., Harris, K., Lipnicki, D. M., Castro‐Costa, E., Lima‐Costa, M. F., Diniz, B. S., ... & Cohort Studies of Memory in an International Consortium (COSMIC). (2023). Sex differences in dementia risk and risk factors: Individual‐participant data analysis using 21 cohorts across six continents from the COSMIC consortium. Alzheimer's & Dementia.

146. The Landmark Study, Canada. (2022)

147. Gilson, A., Taylor, R. A., Chi, L., Haimovich, A. D., Crawford, A., Brandt, C., ... & Hwang, U. (2023). Dementia Risk Analysis Using Temporal Event Modeling on a Large Real-World Dataset. medRxiv, 2023-03.

148. Planche, V., Bouteloup, V., Pellegrin, I., Mangin, J. F., Dubois, B., Ousset, P. J., ... & MEMENTO Study Group. (2023). Validity and performance of blood biomarkers for Alzheimer disease to predict dementia risk in a large clinic-based cohort. Neurology, 100(5), e473-e484.

149. Nissim, N. R., Pham, D. V. H., Poddar, T., Blutt, E., & Hamilton, R. H. (2023). The impact of gamma transcranial alternating current stimulation (tACS) on cognitive and memory processes in patients with mild cognitive impairment or Alzheimer's disease: A literature review. Brain Stimulation.

150. Zhou, D., Li, A., Li, X., Zhuang, W., Liang, Y., Zheng, C. Y., ... & Yuan, T. F. (2022). Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer’s disease: a randomised, double-blind, sham-controlled clinical trial. Journal of Neurology, Neurosurgery & Psychiatry, 93(5), 568-570.

151. Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., ... & Moir, R. D. (2010). The Alzheimer's disease-associated amyloid β-protein is an antimicrobial peptide. PloS one, 5(3), e9505.

152. Nussbaum, J. M., Seward, M. E., & Bloom, G. S. (2013). Alzheimer disease: a tale of two prions. Prion, 7(1), 14-19.

153. Anand, B. G., Prajapati, K. P., Dubey, K., Ahamad, N., Shekhawat, D. S., Rath, P. C., ... & Kar, K. (2019). Self-assembly of artificial sweetener aspartame yields amyloid-like cytotoxic nanostructures. ACS nano, 13(5), 6033-6049.

154. Ylilauri, M. P., Hantunen, S., Lönnroos, E., Salonen, J. T., Tuomainen, T. P., & Virtanen, J. K. (2022). Associations of dairy, meat, and fish intakes with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). European Journal of Nutrition, 61(5), 2531-2542.

155. Marzoughi, S., Banerjee, A., Jutzeler, C. R., Prado, M. A. M., Rosner, J., Cragg, J. J., & Cashman, N. (2021). Tardive neurotoxicity of anticholinergic drugs: A review. Journal of neurochemistry, 158(6), 1334–1344. https://doi.org/10.1111/jnc.15244

156. Kilimann, I., Wucherer, D., Ittermann, T., Völzke, H., Bülow, R., Hoffmann, W., Grabe, H. J., Wittfeld, K., & Teipel, S. J. (2022). Inverse association between the anticholinergic burden and hippocampus volume in a population-based cohort across the entire adult age range. GeroScience, 44(3), 1715–1726. https://doi.org/10.1007/s11357-021-00497-w

157. Guay-Gagnon, M., Vat, S., Forget, M. F., Tremblay-Gravel, M., Ducharme, S., Nguyen, Q. D., & Desmarais, P. (2022). Sleep apnea and the risk of dementia: A systematic review and meta-analysis. Journal of sleep research, 31(5), e13589. https://doi.org/10.1111/jsr.13589

158. Chen, H., Dhana, K., Huang, Y., Huang, L., Tao, Y., Liu, X., ... & Yuan, C. (2023). Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia. JAMA psychiatry.

159. 2022 Alzheimer's disease facts and figures. (2022). Alzheimer's & dementia: the journal of the Alzheimer's Association, 18(4), 700–789. https://doi.org/10.1002/alz.12638

160. McMaster, M., Kim, S., Clare, L., Torres, S. J., Cherbuin, N., DʼEste, C., & Anstey, K. J. (2020). Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL‐CD). Journal of the American Geriatrics Society, 68(11), 2629-2637.

161. Meng, X., Fang, S., Zhang, S., Li, H., Ma, D., Ye, Y., ... & Sun, J. (2022). Multidomain lifestyle interventions for cognition and the risk of dementia: A systematic review and meta-analysis. International Journal of Nursing Studies, 130, 104236.

162. Van den Brink, Annelien C., Elske M. Brouwer-Brolsma, Agnes AM Berendsen, and Ondine van de Rest. "The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer's disease—a review." Advances in Nutrition 10, no. 6 (2019): 1040-1065.

163. Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., ... & Lindquist, S. (2021). APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Science translational medicine, 13(583), eaaz4564.

164. Ndé, C. M. W., Djiogue, S., Awounfack, C. F., Gamo, F. Z., Tedjo, F. M., Tadah, R. N. D., & Njamen, D. (2022). Extra-virgin Avocado (Persea americana Mill., Laucaceae) Oil Improves Cognitive Impairment in D-galactose-induced Alzheimer’s Disease Model on Ovariectomized Wistar Rat.

165. Kim, J. Y. (2021). Optimal diet strategies for weight loss and weight loss maintenance. Journal of obesity & metabolic syndrome, 30(1), 20.

166. Caselli, R. J., Langlais, B. T., Dueck, A. C., Chen, Y., Su, Y., Locke, D. E., ... & Reiman, E. M. (2019). Neuropsychological decline up to 20 years before incident mild cognitive impairment. Alzheimer's & Dementia.

167. Li, G., Larson, E. B., Shofer, J. B., Crane, P. K., Gibbons, L. E., McCormick, W., ... & Thompson, M. L. (2017). Cognitive trajectory changes over 20 years before dementia diagnosis: a large cohort study. Journal of the American Geriatrics Society, 65(12), 2627-2633.

168. Montero-Odasso, M., Ismail, Z., & Livingston, G. (2020). One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case “for” and “against”. Alzheimer's Research & Therapy, 12(1), 1-5.

169. Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., ... & Mukadam, N. (2017). Dementia prevention, intervention, and care. The lancet, 390(10113), 2673-2734.

170. Pereira, M. E., Souza, J. V., Galiciolli, M. E. A., Sare, F., Vieira, G. S., Kruk, I. L., & Oliveira, C. S. (2022). Effects of Selenium supplementation in patients with mild cognitive impairment or alzheimer’s disease: a systematic review and meta-analysis. Nutrients, 14(15), 3205.

171. Tsiknia, A. A., Bergstrom, J., & Reas, E. T. (2023). Midlife omega-3 fatty acid intake predicts later life white matter microstructure in an age-and APOE-dependent manner. Cerebral Cortex, 33(5), 2143-2151.

172. Adeniyi, P. A., Gong, X., MacGregor, E., Degener‐O'Brien, K., McClendon, E., Garcia, M., ... & Back, S. A. (2023). Ferroptosis of microglia in aging human white matter injury. Annals of Neurology.

173. Singer, A. C., Martorell, A. J., Douglas, J. M., Abdurrob, F., Attokaren, M. K., Tipton, J., ... & Tsai, L. H. (2018). Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load. Nature protocols, 13(8), 1850-1868.

174. Suk, H. J., Chan, D., Jackson, B., Fernandez, V., Stark, D., Milman, N., ... & Tsai, L. H. (2020). Sensory gamma frequency stimulation in cognitively healthy and AD individuals safely induces highly coordinated 40 hz neural oscillation: A preliminary study of non‐invasive sensory stimulation for treating Alzheimer’s disease: Dementia care research (research projects; nonpharmacological)/Therapeutic strategies and interventions. Alzheimer's & Dementia, 16, e041146.

175. Agger, M. P., Danielsen, E. R., Carstensen, M. S., Nguyen, N. M., Horning, M., Henney, M. A., ... & Høgh, P. (2023). Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study. Journal of Alzheimer's Disease, (Preprint), 1-13.

176. Lane, K. E., Wilson, M., Hellon, T. G., & Davies, I. G. (2022). Bioavailability and conversion of plant based sources of omega-3 fatty acids–a scoping review to update supplementation options for vegetarians and vegans. Critical reviews in food science and nutrition, 62(18), 4982-4997.

177. Tan, M. H., Bernstein, S. J., Gendler, S., Hanauer, D., & Herman, W. H. (2016). Design, development and deployment of a Diabetes Research Registry to facilitate recruitment in clinical research. Contemporary clinical trials, 47, 202-208.

178. Dowling, N. M., Olson, N., Mish, T., Kaprakattu, P., & Gleason, C. (2012). A model for the design and implementation of a participant recruitment registry for clinical studies of older adults. Clinical Trials, 9(2), 204-214.

179. Grill, J. D., Holbrook, A., Pierce, A., Hoang, D., & Gillen, D. L. (2017). Attitudes toward potential participant registries. Journal of Alzheimer's Disease, 56(3), 939-946.

180. Kluding, P. M., Denton, J., Jamison, T. R., Brooks, W., Blackwell, K., Lantos, J. D., ... & Barohn, R. (2015). Frontiers: integration of a research participant registry with medical clinic registration and electronic health records. Clinical and translational science, 8(5), 405.

181. Fowler, A. J., Dowlut, N., Limb, R., Baldacchino, M. V., Sonagara, V., George, N., ... & Agha, R. A. (2018). Analysis of the first 2645 registrations at the research registry®: A global repository for all study types involving human participants. International Journal of Surgery, 60, 231-235.

182. Cocroft, S., Welsh‐Bohmer, K. A., Plassman, B. L., Chanti‐Ketterl, M., Edmonds, H., Gwyther, L., ... & Burke, J. R. (2020). Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies. Alzheimer's & Dementia, 16(8), 1107-1114.

183. Lee, J. Y., Crooks, R. E., Pham, T., Korngut, L., Patten, S., Jetté, N., ... & Roach, P. (2020). “If it helps someone, then I want to do it”: Perspectives of persons living with dementia on research registry participation. Dementia, 19(8), 2525-2541.

184. Gr